Sumalpong, Benedict J.

HRN: 27-96-81  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/19/2025
CEFUROXIME 750MG (VIAL)
10/19/2025
10/26/2025
IV
750mg
Q8
Abrasions

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Non-compliant To Guidelines